ReShape Lifesciences Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance for Its U.S. Patent Application 17/572,387 Titled "INTRAGASTRIC DEVICE (FOR TREATING OBESITY)"
ReShape Lifesciences Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance for Its U.S. Patent Application 17/572,387 Titled "INTRAGASTRIC DEVICE (FOR TREATING OBESITY)"
ReShape Lifesciences宣佈收到一項名爲 “INTRAGASTRIC設備（用於治療肥胖）” 的美國專利申請的批准通知後，該公司股價走高
ReShape Lifesciences Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance for Its U.S. Patent Application 17/572,387 Titled "INTRAGASTRIC DEVICE (FOR TREATING OBESITY)"
ReShape Lifesciences宣佈收到一項名爲 “INTRAGASTRIC設備（用於治療肥胖）” 的美國專利申請的批准通知後，該公司股價走高
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。